Rhode Island 2026 Regular Session

Rhode Island House Bill H8383

Introduced
4/1/26  

Caption

Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.

Impact

With the establishment of the Rhode Island Prescription Drug Purchasing Pool, the law is anticipated to significantly alter the landscape of prescription drug procurement within the state. By enabling joint purchases, this act could lead to substantial cost savings for local governmental bodies and private enterprises, as they leverage collective bargaining power to negotiate better prices. Additionally, the administration has the authority to regulate eligibility and establish rules for participation, ensuring that the program is efficiently managed and resources are utilized effectively. This framework aims to coordinate with other existing programs to further enhance the price reduction capabilities for state residents.

Summary

House Bill H8383, also known as the Rhode Island Prescription Drug Purchasing Pool Act, introduces a state-operated program designed to facilitate the purchasing of prescription drugs for various employers and health insurance providers. The bill aims to maximize the discounts that can be obtained by participants through collective purchasing. Specifically, it allows nonstate public employers, qualified private employers, and health insurance carriers to purchase prescription medication under the authority stipulated by the state, thereby potentially lowering costs associated with prescription drug expenses for these entities and their members.

Contention

Despite its potential benefits, H8383 may also generate discussions regarding the balance of power between state and local governance. Some opponents might question the implications of a statewide purchasing program on local control over health-related decision-making. Critics could argue that while the intention to reduce costs is commendable, it may unintentionally limit local entities' ability to choose their suppliers or negotiate on their terms. Moreover, the act does not create a risk pool, thereby maintaining the responsibility of each participating entity to cover the full costs, which has been a point of contention in legislative discussions regarding overall accountability and affordability.

Companion Bills

No companion bills found.

Previously Filed As

RI S0468

Prohibits the state, participating ERISA, or any health plan from purchasing referenced drugs for a cost higher than the referenced rate.

RI H5860

Prohibits the state, participating ERISA, or any health plan from purchasing referenced drugs for a cost higher than the referenced rate.

RI H5418

Amends the definition of "small employer" for purposes of the small employer health insurance availability act to mean a business employing less than one hundred (100) employees rather than fifty (50) employees.

RI H5620

Regulates price increases for prescription drugs.

RI S0467

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

RI H5853

Establishes the Wholesale Prescription Drug Importation Program for the importation of wholesale prescription drugs from Canada, to provide savings to Rhode Island consumers.

RI S0114

Prohibits any health insurer, pharmacy benefit manager, manufacturer or other third-party payor from discriminating against any 340B entity participating in a drug discount program.

RI H5634

Prohibits any health insurer, pharmacy benefit manager, manufacturer or other third-party payor from discriminating against any 340B entity participating in a drug discount program.

RI H5116

Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.

RI S0486

Establishes a process whereby large drug manufacturers, may be penalized for prescription drug price increases where there is no, or inadequate, new evidence to support the price increase.

Similar Bills

RI S3257

Establishes a state-run prescription drug purchasing pool, available for participation by nonstate public employers, private employers, and health insurance carriers, to maximize the value of drug discounts available to participants.

NJ A502

Requires prescriptions for animals to be issued in name of animal owner; prohibits unnamed persons from possessing prescribed drugs; and requires Prescription Monitoring Program to include information about controlled substances prescribed by veterinarians.

NJ S518

Permits patients to indicate that they should not be prescribed opiates and certain other controlled substances in prescription monitoring program information.

OH HB324

Enact the Patient Protection Act

OR SB598

Relating to step therapy for nonopioids.

SC S0749

Prescription Medicine Study Committee

IL HB1272

PRESCRIPTION DRUG IMPORT ACT

TX HB1464

Relating to a prescription drug purchasing pool for certain health benefit plan issuers and employers.